Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?

Mastorino, Luca; Roccuzzo, Gabriele; Dapavo, Paolo; Siliquini, Niccolò; Avallone, Gianluca; Rubatto, Marco; Quaglino, Pietro; Ribero, Simone

Mastorino, Luca; Roccuzzo, Gabriele; Dapavo, Paolo; Siliquini, Niccolò; Avallone, Gianluca; Rubatto, Marco; Quaglino, Pietro; Ribero, Simone.

Afiliação

Mastorino L; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Roccuzzo G; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Dapavo P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Siliquini N; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Avallone G; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Rubatto M; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
Ribero S; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.

Dermatol Ther ; 35(9): e15697, 2022 09.

Article em En | MEDLINE | ID: mdl-35796147

Assuntos

Interleucina-17; Interleucina-23; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-17 / Interleucina-23 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google